Tuesday, August 26, 2014 10:09:18 AM
http://www.evaluategroup.com/Universal/View.aspx?type=Report&id={23D6C352-1933-41D7-A788-054D46E19AAA}¶ms=%3CPARAMS%20currencyId=%220%22%3E%3CPARAM%20linkKind=%221%22%20compId=%221019%22%20name=%22allergy%22%20itemId=%225b%22%20/%3E%3C/PARAMS%3E
We know the settlement date is June 2015 - any other detail(s) of the settlement is confidential. I don't trust the information contained on the site above that notes Antares as the company when it should be TEVA and then notes a world wide launch of 9/30/2014. I've seen nothing from TEVA pr about a pending worldwide launch of the generic epipen. If TEVA is not barred from launching world wide as per the settlement date of June 2015, then why aren't they already marketing worldwide? They certainly have the pens in stock.
Getting into the worldwide market (ex US & Canada) would be nice (while not producing very good margins) so I don't assign any meaningful financial benefit to WW. The big bucks is connected with June 2015 and the US/Canada market.
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM